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ing cannulation, despite the purse string
attaching the aortic cannula.
In our opinion, central cannulation is
safe in acute aortic dissection repair, re-
gardless of the systematic need for an open
distal anastomosis, and the race to find the
best arterial perfusion site seems useless
since the evidence is right before every-
body’s eyes.
Fadi Farhat, MD, PhD
Thomas Sassard, MD
Olivier Jegaden, MD
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Reply to the Editor:
We appreciate the comments from Drs
Farhat, Sassard, and Jegaden on our arti-
cle describing our experience with direct
cannulation of dissected ascending aorta.
They add further evidence speaking to
the safety of this technique in specific
subpopulations of patients with this dis-
ease. Their group uses this technique
widely but avoids using it in dissections
with suspected rupture or hematoma.
Their exclusion criteria were similar to
our study. As they describe, we have also
placed purse strings in the aorta to secure
the cannula without incident. This com-
bined experience speaks to the feasibility
of the central cannulation in ascending
aortic dissections, which remains a safe
cannulation option in selected situations
for surgeons dealing with this disease.
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A meta-analysis of minimally
invasive coronary artery bypass
versus percutaneous coronary
intervention with stenting for
isolated left anterior descending
artery disease is indispensable
To the Editor:
We read with great interest a meta-analysis
of randomized trials of off-pump coronary
artery bypass versus percutaneous coronary
intervention (PCI) by Bainbridge and asso-
ciates.1 In response to a meta-analysis by
Boodhwani and colleagues2 of randomized
trials comparing surgical versus percutane-
ous treatment of isolated left anterior de-
scending (LAD) artery disease, we3 con-
ducted a meta-analysis of then-available 5
trials of minimally invasive direct coronary
artery bypass (MIDCAB) versus PCI with
stenting in the form of a letter to the editor.
In the meta-analysis by Boodhwani and
coworkers,2 significant heterogeneity ex-
isted because of the inclusion of both
conventional coronary artery bypass and
MIDCAB in the surgical group and both
PCI with or without stenting in the percu-
taneous group. So far as the meta-analysis
by Bainbridge and associates1 is con-
cerned, although 5 of 6 included trials used
MIDCAB technique in the majority of pa-
tients in the surgical arm, in 1 trial by
Eefting and colleagues4 (the largest trial in
the 6 trials) surgical access to the heart was
achieved via median sternotomy in 67%.
Although the trial by Eefting and cowork-
ers4 included patients with multivessel dis-
ease, the other 5 trials were exclusively of
LAD stenting versus left internal thoracic
artery–to–LAD anastomosis. Furthermore,
a flaw of the systematic review by Bain-
bridge and associates1 was missing a trial
by Kim and colleagues5 published in 2005
despite comprehensive searches up until
May 2006. Therefore, we would like to
advocate a meta-analysis of currently avail-
able 6 homogeneous randomized trials of
MIDCAB versus PCI with stenting for iso-
lated LAD disease, including the trial by
Kim and coworkers5 and 5 trials except for
the trial by Eefting and associates4 in-
cluded in the meta-analysis by Bainbridge
and colleagues.1
Hisato Takagi, MD, PhD
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Reply to the Editor:
Takagi and colleagues are correct in sug-
gesting that the trial by Kim and associ-
ates1 is relevant to our meta-analysis of
randomized trials of off-pump coronary ar-
tery bypass/minimally invasive direct cor-
onary artery bypass (OPCAB/MIDCAB)
versus percutaneous coronary intervention
(PCI).2 We remain uncertain why this ran-
domized trial was not identified despite
multiple independent searches performed
by experts. It may be that the trial was not
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indexed on Medline at the time of our
search, or it may have been available on
Medline but indexed incorrectly. Either
way, it highlights the limitations of elec-
tronic searches for the purpose of identify-
ing all relevant trials for meta-analyses.
One can never be certain that all trials have
been identified, and empiric evidence sug-
gests that up to 50% of relevant articles may
be missed despite vigilance in searching.3
As suggested by Takagi and colleagues,
we have added this trial to our meta-analysis
and would like to share the results to pro-
vide readers with the most current esti-
mates of clinical outcomes. Adding this
trial of MIDCAB versus PCI (n  100)
resulted in increased power and narrower
confidence intervals for the outcomes of
reintervention, death, stroke, angina recur-
rence, and myocardial infarction. The up-
dated results are provided in Table 1. Over-
all, none of the conclusions changed.
Regarding the suggestion that the trial
by Eefting and associates4 may introduce
heterogeneity, we performed a sensitivity
analysis by excluding this trial from the
analysis to determine the impact on results.
The results were not materially changed by
excluding Eefting. This may be because
similar results are achievable, whether the
procedure is delivered through OPCAB or
MIDCAB and whether single or multiple
vessels are anastomosed. On the other
hand, it may simply be that the analysis is
underpowered to detect important differ-
ences between subgroups. When the confi-
dence intervals around the nonsignificant
outcomes are examined, it is clear that im-
portant differences in outcomes have not been
ruled out, and further research will be re-
quired to enlighten any potential differ-
ences among subgroups. As Takagi and
colleagues have highlighted, the results of
this analysis should not be automatically
assumed to apply to OPCAB performed on
multivessel disease, inasmuch as this group
was underrepresented.
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Leave the left atrial appendage
untouched for stroke prevention!
To the Editor:
We read the article by Kamohara and col-
lesgues1 regarding the short-term and mid-
term effects of left atrial appendage (LAA)
occlusion on left atrial (LA) function with
great interest. An atrial exclusion device
was applied by means of thoracotomy in 19
mongrel dogs in sinus rhythm, and hemo-
dynamic, as well as echocardiographic,
data were recorded immediately and after 7
and 90 days. The authors found that LAA
exclusion might affect LA reservoir func-
tion. We would like to congratulate the
authors for their important study. However,
there still remain the following questions:
1. When measuring the LA area by
means of planimetry before LAA ex-
clusion, was the LAA area included
or excluded? If it was included, this
might well explain the decrease in LA
volume and area after LAA exclusion,
as listed in Table 1. If the LAA area
was not included, how do the authors
then explain the decrease in LA area
and volume?
2. There is a great variation in human
LAA size.2 We do not know whether
this is also true for the canine LAA.
What was the size of the excluded
LAAs, and was there any associa-
tion between LAA size and the he-
modynamic or Doppler measure-
ments?
3. The LAA is known as an important
site of natriuretic peptide secretion.3
Were serum levels of natriuretic pep-
tides measured before the procedure
and during follow-up? Did the au-
thors observe weight gain caused by
fluid retention after LAA occlusion?
4. It is known that in guinea pigs LAA
exclusion leads to a decrease in car-
diac output.4 If the investigated
dogs are still alive, it would be very
interesting to continue follow-up,
measure cardiac output and func-
tional parameters, and compare
them with those from control dogs
with the LAA left intact.
TABLE 1
Outcome OPCAB (%) PCI (%) OR (95% CI) I2 (%) P value for effect
Death, in hospital 1.1 0.4 1.88 (0.56–6.36) 0 .31
AMI, in hospital 2.7 2.8 1.04 (0.48–2.25) 0 .92
Stroke, in hospital 0.5 0.21 1.11 (0.35–2.49) 0 .64
Stroke, 1-5 y 0 1.3 0.34 (0.05–2.38) 0 .4
Angina recurrence, 1-5 y 11.7 22.8 0.44 (0.24–0.83) 38 .01
Reintervention, in hospital 2.3 3.4 0.74 (0.35–1.55) 0 .42
Reintervention, 1-5 y 5.3 19.1 0.23 (0.15–0.38) 0 .0001
OPCAB, Off-pump coronary artery bypass; PCI, percutaneous coronary intervention; OR, odds ratio; CI, confidence interval; AMI, acute myocardial
infarction.
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